β-Thujaplicin reduced proliferation in MCF7 cells, suppressed cancer stemness in glioma U87MG, induced cell cycle arrest, apoptosis, and DNA methylation via DNMT1 and UHRF1 in colon cancer, and restricted liver cancer growth by apoptosis and cell cycle arrest46–50. Here, UHRF1 is linked to central nervous system cancer.